The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Ampisol 2g

Franklin Pharmaceuticals Ltd.VPA10976/013/001

Main Information

Trade NameAmpisol 2g
Active SubstancesAmpicillin (as ampicillin sodium ph.eur.)
Dosage FormPowder for solution for injection
Licence HolderFranklin Pharmaceuticals Ltd.
Licence NumberVPA10976/013/001

Group Information

ATC CodeQJ01CA01 ampicillin
Therapeutic ClassAntibacterial


License statusAuthorised
Licence Issued18/12/1991
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back